title: Effects of pentoxifylline on liver regeneration: a double-blinded, randomized, controlled trial in 101 patients undergoing major liver resection.
authors.affiliation: Swiss HPB (Hepato-Pancreato-Biliary) Center, Departments of Surgery, University Hospital Zurich, Zurich, Switzerland.
authors.forename: Henrik
authors.initials: H
authors.lastname: Petrowsky
authors.forename: Stefan
authors.initials: S
authors.lastname: Breitenstein
authors.forename: Ksenija
authors.initials: K
authors.lastname: Slankamenac
authors.forename: Diana
authors.initials: D
authors.lastname: Vetter
authors.forename: Kuno
authors.initials: K
authors.lastname: Lehmann
authors.forename: Stefan
authors.initials: S
authors.lastname: Heinrich
authors.forename: Michelle L
authors.initials: ML
authors.lastname: DeOliveira
authors.forename: Wolfram
authors.initials: W
authors.lastname: Jochum
authors.forename: Dominik
authors.initials: D
authors.lastname: Weishaupt
authors.forename: Thomas
authors.initials: T
authors.lastname: Frauenfelder
authors.forename: Rolf
authors.initials: R
authors.lastname: Graf
authors.forename: Pierre-Alain
authors.initials: PA
authors.lastname: Clavien
mesh_terms: D001706:Biopsy; D004311:Double-Blind Method; D005260:Female; D006498:Hepatectomy; D006801:Humans; D007262:Infusions, Intravenous; D015850:Interleukin-6 / Q000378:metabolism; D008107:Liver Diseases / Q000601:surgery*; D008111:Liver Function Tests; D008115:Liver Regeneration / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D010431:Pentoxifylline / Q000008:administration & dosage / Q000494:pharmacology*; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D011183:Postoperative Complications; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D015850:Interleukin-6; D010726:Phosphodiesterase Inhibitors; D014409:Tumor Necrosis Factor-alpha; D010431:Pentoxifylline